FS-67 in the Treatment of Pediatric Patients With Ankle Sprain
Public ClinicalTrials.gov record NCT01037816. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Assess the Efficacy and Safety of FS-67 Patches in Adolescent Subjects With Ankle Sprain
Study identification
- NCT ID
- NCT01037816
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Lead sponsor
- Hisamitsu Pharmaceutical Co., Inc.
- Industry
- Enrollment
- 252 participants
Conditions and interventions
Conditions
Interventions
- FS-67 Patch Drug
- Placebo Patch Other
Drug · Other
Eligibility (public fields only)
- Age range
- 13 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 30, 2009
- Primary completion
- Oct 31, 2010
- Completion
- Nov 30, 2010
- Last update posted
- Oct 5, 2022
2009 – 2010
United States locations
- U.S. sites
- 23
- U.S. states
- 13
- U.S. cities
- 22
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Hisamitsu Investigator Site | Birmingham | Alabama | 35209 | — |
| Hisamitsu Investigator Site | Tucson | Arizona | 85705 | — |
| Hisamitsu Investigator Site | Tucson | Arizona | 85712 | — |
| Hisamitsu Investigator Site | Hot Springs | Arkansas | 71913 | — |
| Hisamitsu Investigator Site | Anaheim | California | 92804 | — |
| Hisamitsu Investigator Site | Bell Gardens | California | 90201 | — |
| Hisamitsu Investigator Site | Long Beach | California | 90806 | — |
| Hisamitsu Investigator Site | Los Angeles | California | 90036 | — |
| Hisamitsu Investigator Site | Boynton Beach | Florida | 33472 | — |
| Hisamitsu Investigator Site | Daytona Beach | Florida | 32117 | — |
| Hisamitsu Investigator Site | Doral | Florida | 33166 | — |
| Hisamitsu Investigator Site | Jacksonville | Florida | 32216 | — |
| Hisamitsu Investigator Site | Evansville | Indiana | 47714 | — |
| Hisamitsu Investigator Site | Topeka | Kansas | 66604 | — |
| Hisamitsu Investigator Site | Bellevue | Nebraska | 68005 | — |
| Hisamitsu Investigator Site | Lincoln | Nebraska | 68510 | — |
| Hisamitsu Investigator Site | Las Vegas | Nevada | 89106 | — |
| Hisamitsu Investigator Site | Berlin | New Jersey | 08009 | — |
| Hisamitsu Investigator Site | Charlotte | North Carolina | 28207 | — |
| Hisamitsu Investigator Site | Columbus | Ohio | 43214 | — |
| Hisamitsu Investigator Site | Dayton | Ohio | 45432 | — |
| Hisamitsu Investigator Site | El Paso | Texas | 79902 | — |
| Hisamitsu Investigator Site | Grapevine | Texas | 76051 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01037816, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 5, 2022 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01037816 live on ClinicalTrials.gov.